Stock SNNAQ SIENNA BIOPHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Sienna Biopharmaceuticals, Inc.

Equities

SNNAQ

US82622H1086

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 18:22:47 25/03/2024 GMT 		5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Sienna Biopharmaceuticals, Inc. -.--% -.--%
2021 Motion for Asset Sale Approved for Sienna Biopharmaceuticals, Inc. CI
2021 Avro Life Sciences, Inc. entered into an agreement to acquire Certain Assets of Sienna Biopharmaceuticals, Inc. (OTCPK:SNNA.Q) for $0.1 million. CI

Business Summary

Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on bringing scientific innovations to patients whose lives remain burdened by their disease. Its lead candidate from its platform, SNA-120, is an inhibitor of Tropomyosin receptor kinase A (TrkA) for the treatment of psoriasis, as well as the associated pruritus (itch). The Company's second product candidate, SNA-125, is a dual Janus kinase 3 (JAK3)/TrkA inhibitor for the treatment of atopic dermatitis, psoriasis and the associated pruritus. In addition, the Company also offers SNA-001, a silver photo particle technology derived from its Topical Photoparticle Therapy platform.

Number of employees: 13

Managers

Managers TitleAgeSince
Frederick C. Beddingfield FOU
 Founder 59 26/06/10
Majed Kheir COO
 Chief Operating Officer 46 31/12/15
Silvio Traversa CTO
 Chief Tech/Sci/R&D Officer 54 30/11/16
Sean P. Andrews IRC
 Investor Relations Contact - -
Timothy Kirk Andrews LAW
 General Counsel 45 30/09/16

Members of the board

Members of the board TitleAgeSince
Dennis Fenton BRD
 Director/Board Member 72 30/09/16
Frederick C. Beddingfield FOU
 Founder 59 26/06/10

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 31,050,542 30,907,542 ( 99.54 %) 143,000 ( 0.4605 %) 99.54 %

Company contact information

Sienna Biopharmaceuticals, Inc.

30699 Russell Ranch Road Suite 140

91362, Westlake Village

+

address Sienna Biopharmaceuticals, Inc.(SNNAQ)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
SIENNA BIOPHARMACEUTICALS, INC. Stock Sienna Biopharmaceuticals, Inc.
-.--% 22
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-1.65% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+6.75% 101B
ARGENX SE Stock argenx SE
+6.84% 23.07B
BIONTECH SE Stock BioNTech SE
-12.60% 22.23B
GENMAB A/S Stock Genmab A/S
-5.20% 18.05B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-39.98% 17.18B
BEIGENE, LTD. Stock BeiGene, Ltd.
-10.17% 16.94B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+6.12% 14.07B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+35.47% 12.35B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. SNNAQ Stock
  4. Company Sienna Biopharmaceuticals, Inc.